News Conference News ESC 2025 ESC/EACTS Release New Valvular Heart Disease Guidelines Yael L. Maxwell September 03, 2025
News Conference News ESC 2025 DOUBLE-CHOICE: Minimalist Anesthesia for TAVI Comparable to Standard Care Todd Neale August 30, 2025
News Conference News ESC 2024 Balloon-Expandable TAVI Superior to SAVR in Women at 1 Year: RHEIA Caitlin E. Cox September 04, 2024
News Conference News ESC 2021 2021 ESC/EACTS Valve Guidelines Unveil TAVI/SAVR Age Cutoffs and Earlier Care Shelley Wood August 31, 2021
News Conference News ESC 2021 New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT Shelley Wood August 28, 2021
News Conference News ESC 2017 Leaflet Thrombosis After TAVR Tied to Cardiogenic Shock and Death Yael L. Maxwell September 01, 2017
News Conference News ESC 2017 European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts Shelley Wood August 27, 2017
News Conference News ESC 2014 ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall Todd Neale September 08, 2014
Presentation ESC 2014 Two- year clinical outcome of post procedural mitral regurgitation after transcatheter aortic valve replacement Presenter: Biner S. Finkelstein September 03, 2014
News Conference News ESC 2014 Mitral Regurgitation Associated with Decreased Survival in TAVR Patients Yael L. Maxwell September 03, 2014
News Conference News ESC 2014 GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular Caitlin E. Cox September 02, 2014
News Conference News ESC 2014 FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients Yael L. Maxwell September 02, 2014
News Conference News ESC 2014 Single-Center Study Compares TAVR Devices in Mixed Aortic Stenosis Caitlin E. Cox August 31, 2014
News Conference News ESC 2013 ESC Congress 2013: Mix of Trials with Potential to Reshape Practice September 09, 2013
News Conference News ESC 2013 PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk Yael L. Maxwell September 04, 2013
News Conference News ESC 2013 New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups Caitlin E. Cox September 03, 2013
News Conference News ESC 2013 FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk Caitlin E. Cox September 02, 2013
News Conference News ESC 2012 ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations Caitlin E. Cox September 04, 2012
News Conference News ESC 2012 French, European Registries Add International Flavor to TAVR Assessment August 29, 2012
News Conference News ESC 2012 Dedicated Transapical TAVR Device Shows Promise in Premarket Clinical Research Caitlin E. Cox August 28, 2012